November 4, 2015 / 2:06 PM / 2 years ago

BUZZ-Retrophin Inc: U.S. senators probe pharmaceutical drug pricing

** Drugmaker's shares down 10 pct at $19.50 premarket

** Two U.S. senators launched a bipartisan investigation into pharmaceutical drug pricing on Wednesday, requesting documents from four drugmakers, including Retrophin and Valeant Pharmaceuticals International Inc

** Valeant's U.S.-listed shares up 1.2 pct at $99.10

** The other companies being investigated are privately held Turing Pharmaceuticals and Rodelis Therapeutics

** Shares of many drugmakers have slumped since Democratic presidential hopeful Hillary Clinton last month proposed ways to prevent industry "profiteering.

** Up to Tuesday's close, Retrophin's stock had fallen about 24 pct since Sept. 21 when Clinton tweeted her intent to tackle unnecessarily high prices in some drug markets

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below